DraftKings Inc vs Novavax Inc — how do they compare? DraftKings Inc trades at $25.23 (market cap $12.58B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: DraftKings Inc is far larger — about 9.6× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.
| DKNG | NVAX | |
|---|---|---|
Market Cap | $12.58B | $1.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $48.23 | $11.19 |
52-Week Low | $20.72 | $6.22 |
Enterprise Value | $13.51B | $889.30M |
Trailing returns across standard periods
Latest headlines on both assets
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →